earnings
NASDAQ · TECH
Bio-Techne Corporation
Healthcare · Biotechnology
$72.34
Up+$0.07 (+0.10%)
Updated Sep 16, 2026, 7:54 AM
SID Score
5.6/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.45B
- P/E ratio
- 120.15
- Dividend yield
- 0.44%
- 52-week range
- $43.20 – $72.62
- Volume
- 2.93M
- Avg. volume
- 2.21M
Price performance
TECH price history
1M range · 20 trading sessions · Daily adjusted prices
TECH closed at $72.34 after 20 trading sessions, up 0.17% for the selected period.
- Last close
- $72.34
- Period change
- +0.17%
- Period low
- $72.08
- Period high
- $72.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $72.28 | $72.39 | $72.205 | $72.34 | 2.93M |
| Sep 14, 2026 | $72.21 | $72.299 | $72.17 | $72.27 | 2.74M |
| Sep 11, 2026 | $72.15 | $72.38 | $72.12 | $72.12 | 2.72M |
| Sep 10, 2026 | $72.28 | $72.325 | $72.08 | $72.08 | 3.82M |
| Sep 9, 2026 | $72.30 | $72.365 | $72.23 | $72.25 | 1.99M |
| Sep 8, 2026 | $72.37 | $72.46 | $72.29 | $72.31 | 2.07M |
| Sep 4, 2026 | $72.40 | $72.48 | $72.40 | $72.43 | 1.86M |
| Sep 3, 2026 | $72.36 | $72.58 | $72.32 | $72.45 | 2.54M |
| Sep 2, 2026 | $72.20 | $72.38 | $72.20 | $72.30 | 1.66M |
| Sep 1, 2026 | $72.36 | $72.39 | $72.14 | $72.18 | 2.9M |
| Aug 31, 2026 | $72.375 | $72.41 | $72.30 | $72.31 | 2.2M |
| Aug 28, 2026 | $72.40 | $72.48 | $72.32 | $72.35 | 1.63M |
| Aug 27, 2026 | $72.38 | $72.50 | $72.35 | $72.47 | 1.68M |
| Aug 26, 2026 | $72.33 | $72.40 | $72.325 | $72.38 | 1.39M |
| Aug 25, 2026 | $72.35 | $72.38 | $72.28 | $72.33 | 1.9M |
| Aug 24, 2026 | $72.29 | $72.415 | $72.27 | $72.39 | 2M |
| Aug 21, 2026 | $72.32 | $72.35 | $72.27 | $72.32 | 3.96M |
| Aug 20, 2026 | $72.36 | $72.51 | $72.23 | $72.28 | 3.54M |
| Aug 19, 2026 | $72.40 | $72.555 | $72.38 | $72.48 | 2.51M |
| Aug 18, 2026 | $72.41 | $72.515 | $72.22 | $72.22 | 2.56M |
Latest TECH news
The latest Smart Investors Daily articles mentioning TECH.
Stock researchCompany · Overview
TECH research
Overview
Company profile and research snapshot.
Company profile
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $69.67
- Implied upside
- —
- Analysts
- 23
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 9, 2026 | RBC Capital | Sector Perform | — |
| Jun 30, 2026 | Benchmark | Hold | — |
| Jun 30, 2026 | TD Cowen | Hold | — |
| Jun 29, 2026 | Citigroup | Neutral | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.